DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer

FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy

(2015) G. Kim et al.   CLINICAL CANCER RESEARCH

REV7 counteracts DNA double-strand break resection and affects PARP inhibition

(2015) Guotai Xu et al.   NATURE

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

(2015) Joaquin Mateo et al.   NEW ENGLAND JOURNAL OF MEDICINE

PTEN regulates DNA replication progression and stalled fork recovery

(2015) Jinxue He et al.   Nature Communications

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

NQO1 Suppresses NF- B-p300 Interaction to Regulate Inflammatory Mediators Associated with Prostate Tumorigenesis

(2014) D. Thapa et al.   CANCER RESEARCH

Prostate cancer: the need for biomarkers and new therapeutic targets

(2014) Juliana Felgueiras et al.   Journal of Zhejiang University-SCIENCE B

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Role of osteopontin in the pathophysiology of cancer

(2014) Lalita A. Shevde et al.   MATRIX BIOLOGY

Tissue fixation and the effect of molecular fixatives on downstream staining procedures

(2014) William J. Howat et al.   METHODS

Transcriptional Roles of PARP1 in Cancer

(2014) Matthew J. Schiewer et al.   MOLECULAR CANCER RESEARCH

Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: Implications for the anti-tumor barrier concept and treatment

(2014) Jirina Bartkova et al.   Molecular Oncology

Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data

(2014) Julia L. Williams et al.   Cancer Genetics

The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis

(2013) K Evangelou et al.   CELL DEATH AND DIFFERENTIATION

JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1–mediated chromatin response to DNA breaks

(2013) Sugiko Watanabe et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

53BP1 Regulates DSB Repair Using Rif1 to Control 5' End Resection

(2013) M. Zimmermann et al.   SCIENCE

Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients

(2013) Funda Kosova et al.   TUMOR BIOLOGY

Functional Activation of ATM by the Prostate Cancer Suppressor NKX3.1

(2013) Cai Bowen et al.   Cell Reports

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians

(2012) Christine G. Stoehr et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

The DNA damage response and cancer therapy

(2012) Christopher J. Lord et al.   NATURE

Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer

(2011) J. Chad Brenner et al.   CANCER CELL

Prostate cancer and inflammation: the evidence

(2011) Karen S Sfanos et al.   HISTOPATHOLOGY

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers

(2011) Siwanon Jirawatnotai et al.   NATURE

Cyclin D1 multitasks

(2011) Jiri Bartek et al.   NATURE

More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance

(2011) Jiri Lukas et al.   NATURE CELL BIOLOGY

Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer

(2011) Ana Aparicio et al.   Nature Reviews Urology

NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector

(2010) Albena T. Dinkova-Kostova et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Dietary Glucosinolate Intake, Polymorphisms in Selected Biotransformation Enzymes, and Risk of Prostate Cancer

(2010) A. Steinbrecher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue

(2010) S. Jaamaa et al.   CANCER RESEARCH

Poly(ADP-Ribose) Polymerase Inhibition: "Targeted" Therapy for Triple-Negative Breast Cancer

(2010) C. K. Anders et al.   CLINICAL CANCER RESEARCH

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

(2010) Peter Bouwman et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

(2010) J Bartkova et al.   ONCOGENE

Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer

(2010) Jan Bouchal et al.   PROSTATE

Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors

(2009) Ana M. Mendes-Pereira et al.   EMBO Molecular Medicine

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

(2008) Rainer Fagerholm et al.   NATURE GENETICS

An Oncogene-Induced DNA Damage Model for Cancer Development

(2008) T. D. Halazonetis et al.   SCIENCE